On 10/22/24, Marker Therapeutics Inc (NASDAQ: MRKR) stock enjoyed a major increase of 22.7%, closing at $4.54. Moreover, trading volume in this advance was exceptionally high at 474% of normal. The stock has risen 33.9% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to fall short of the cost of capital, MRKR is expected to be a modest Value Eraser.
Marker Therapeutics has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Marker Therapeutics has a very low Power Rating of 13 and a very low Appreciation Score of 10, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment